Correlation Between GlaxoSmithKline PLC and Telo Genomics
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Telo Genomics Corp, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Telo Genomics.
Diversification Opportunities for GlaxoSmithKline PLC and Telo Genomics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between GlaxoSmithKline and Telo is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Telo Genomics go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Telo Genomics
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.21 times more return on investment than Telo Genomics. However, GlaxoSmithKline PLC ADR is 4.71 times less risky than Telo Genomics. It trades about 0.02 of its potential returns per unit of risk. Telo Genomics Corp is currently generating about 0.0 per unit of risk. If you would invest 3,400 in GlaxoSmithKline PLC ADR on January 23, 2025 and sell it today you would earn a total of 263.00 from holding GlaxoSmithKline PLC ADR or generate 7.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.74% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Telo Genomics Corp
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Telo Genomics Corp |
GlaxoSmithKline PLC and Telo Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Telo Genomics
The main advantage of trading using opposite GlaxoSmithKline PLC and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Telo Genomics vs. Berkshire Hathaway CDR | Telo Genomics vs. JPMorgan Chase Co | Telo Genomics vs. Alphabet Inc CDR | Telo Genomics vs. Bank of America |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |